Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.

Leal FE, Ndhlovu LC, Hasenkrug AM, Bruno FR, Carvalho KI, Wynn-Williams H, Neto WK, Sanabani SS, Segurado AC, Nixon DF, Kallas EG.

PLoS Negl Trop Dis. 2013;7(2):e2028. doi: 10.1371/journal.pntd.0002028. Epub 2013 Feb 7.

2.

The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis.

Michaëlsson J, Barbosa HM, Jordan KA, Chapman JM, Brunialti MK, Neto WK, Nukui Y, Sabino EC, Chieia MA, Oliveira AS, Nixon DF, Kallas EG.

BMC Immunol. 2008 Jul 29;9:41. doi: 10.1186/1471-2172-9-41.

3.

Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.

Pinto MT, Malta TM, Rodrigues ES, Pinheiro DG, Panepucci RA, Malmegrim de Farias KC, Sousa Ade P, Takayanagui OM, Tanaka Y, Covas DT, Kashima S.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):610-22. doi: 10.1089/AID.2013.0109. Epub 2013 Oct 16.

4.

HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.

Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M.

Retrovirology. 2012 May 30;9:46. doi: 10.1186/1742-4690-9-46.

5.

Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

Ndhlovu LC, Snyder-Cappione JE, Carvalho KI, Leal FE, Loo CP, Bruno FR, Jha AR, Devita D, Hasenkrug AM, Barbosa HM, Segurado AC, Nixon DF, Murphy EL, Kallas EG.

Clin Exp Immunol. 2009 Dec;158(3):294-9. doi: 10.1111/j.1365-2249.2009.04019.x. Epub 2009 Sep 2.

6.

Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR.

J Immunol. 2004 Feb 1;172(3):1735-43.

7.

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.

Goncalves DU, Proietti FA, Barbosa-Stancioli EF, Martins ML, Ribas JG, Martins-Filho OA, Teixeira-Carvalho A, Peruhype-Magalhães V, Carneiro-Proietti AB.

Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107. Review.

PMID:
18691139
8.

IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.

Best I, López G, Verdonck K, González E, Tipismana M, Gotuzzo E, Vanham G, Clark D.

Immunology. 2009 Sep;128(1 Suppl):e777-86. doi: 10.1111/j.1365-2567.2009.03082.x. Epub 2009 Feb 17.

9.

Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, Izumi T, Fujita H, Aratani S, Yagishita N, Fujii R, Nishioka K, Jacobson S, Nakajima T.

PLoS One. 2009 Aug 5;4(8):e6517. doi: 10.1371/journal.pone.0006517.

10.

Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Starling AL, Martins-Filho OA, Lambertucci JR, Labanca L, de Souza Pereira SR, Teixeira-Carvalho A, Martins ML, Ribas JG, Carneiro-Proietti AB, Gonçalves DU.

Acta Trop. 2013 Jan;125(1):75-81. doi: 10.1016/j.actatropica.2012.09.012. Epub 2012 Sep 27.

PMID:
23022356
11.

Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.

Saito M, Braud VM, Goon P, Hanon E, Taylor GP, Saito A, Eiraku N, Tanaka Y, Usuku K, Weber JN, Osame M, Bangham CR.

Blood. 2003 Jul 15;102(2):577-84. Epub 2003 Jan 30.

12.

T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

Casseb J, Posada-Vergara MP, Montanheiro P, Fukumori LM, Olah I, Smid J, Duarte AJ, Penalva de Oliveira AC.

Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):231-3.

13.

Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.

Mukae H, Kohno S, Morikawa N, Kadota J, Matsukura S, Hara K.

Microbiol Immunol. 1994;38(1):55-62.

14.

Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.

Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalhães E, Melo A, Dutra WO, Gollob KJ, Carvalho EM.

BMC Infect Dis. 2004 Mar 2;4:7.

15.

Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.

Dwyer KM, Hanidziar D, Putheti P, Hill PA, Pommey S, McRae JL, Winterhalter A, Doherty G, Deaglio S, Koulmanda M, Gao W, Robson SC, Strom TB.

Am J Transplant. 2010 Nov;10(11):2410-20. doi: 10.1111/j.1600-6143.2010.03291.x.

16.

Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.

Araya N, Sato T, Yagishita N, Ando H, Utsunomiya A, Jacobson S, Yamano Y.

Viruses. 2011 Sep;3(9):1532-48. doi: 10.3390/v3091532. Epub 2011 Aug 25. Review.

17.

Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.

Sarkis S, Belrose G, Peloponese JM Jr, Olindo S, Césaire R, Mesnard JM, Gross A.

J Clin Virol. 2013 Sep;58(1):295-8. doi: 10.1016/j.jcv.2013.05.006. Epub 2013 Jun 4.

PMID:
23756056
18.

Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.

Eiraku N, Hingorani R, Ijichi S, Machigashira K, Gregersen PK, Monteiro J, Usuku K, Yashiki S, Sonoda S, Osame M, Hall WW.

J Immunol. 1998 Dec 15;161(12):6674-80.

19.

Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil.

Brito-Melo GE, Martins-Filho OA, Carneiro-Proietti AB, Catalan-Soares B, Ribas JG, Thorum GW, Barbosa-Stancioli EF; Grupo Interdisciplinar de Pesquisas Em HTLV.

Scand J Immunol. 2002 Jun;55(6):621-8.

20.

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Menezes SM, Decanine D, Brassat D, Khouri R, Schnitman SV, Kruschewsky R, López G, Alvarez C, Talledo M, Gotuzzo E, Vandamme AM, Galvão-Castro B, Liblau R, Weyenbergh JV.

J Neuroinflammation. 2014 Jan 29;11:18. doi: 10.1186/1742-2094-11-18.

Supplemental Content

Support Center